Amblyopia therapy: An update

Strabismus

Volumn 19, Issue 3, 2011, Pages 91-98

  Stewart, Catherine E ^a,b   Moseley, Merrick J ^a   Fielder, Alistair R ^a  

^a CITY UNIVERSITY   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

atropine occlusion; compliance; patching; refractive adaptation

Indexed keywords

ATROPINE;

AMBLYOPIA; CHILD; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; EDUCATION; EVIDENCE BASED PRACTICE; EYELID CLOSURE; HUMAN; MEDICAL DECISION MAKING; MOTIVATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTION ERROR; TREATMENT OUTCOME; VISUAL ACUITY;

AMBLYOPIA; ATROPINE; HUMANS; MYDRIATICS; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; SENSORY DEPRIVATION;

EID: 80052211629     PISSN: 09273972     EISSN: 17445132     Source Type: Journal    
DOI: 10.3109/09273972.2011.600421     Document Type: Conference Paper

References (31)

1. Awan M, Proudlock FA, Gottlob I. A randomised controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitor to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435-1439. (Pubitemid 41685886)
2. Cole SR, Beck RW, Moke PS, et al. The Amblyopia Treatment Index. J AAPOS. 2001;5:250-254. (Pubitemid 33601296)
3. Cotter SA, Holmes JM, Foster N, Melia M, Pediatric Eye Disease Investigator Group. Optical treatment of strabismic and combined strabismic-anisometropic amblyopia IOVS E-ABSTRACT; 2011.
4. Dixon-Woods M, Awan M, Gottlob I. Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study. Arch Dis Child. 2006;91:491-494. (Pubitemid 43836099)
5. Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ. Compliance monitoring in amblyopia therapy: Objective monitoring of occlusion. Br J Ophthalmol. 1995;79:585-589.
6. Foley-Nolan A, McCann A, O'Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol. 1997;81:54-57. (Pubitemid 27068164)
7. Holmes JM, Repka MX, Kraker RT, Clarke MP. Treating of amblyopia. Strabismus. 2006;14:37-42.
8. Loudon SE, Polling JR, Simonsz HJ. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase. Graefes Arch Clin Exp Ophthalmol. 2003;24:176-180. (Pubitemid 36747809)
9. Loudon SE, Passchier J, Chaker L, et al. Psychological causes of non-compliance with electronically monitored occlusion therapy for amblyopia. Br J Ophthalmol. 2009;93:1499-1503.
10. Loudon SE, Fronius M, Looman C, Awan M, Simonsz M, van der Maas, et al. Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci. 2006;47: 4393-4400. (Pubitemid 46579364)
11. Massie H. Fixing eye for occlusion: Survey of 1,000 cases of patients receiving occlusion of the fixing eye. Trans Ophthalmol Soc Aust. 1965;24:39-46.
12. Moseley MJ, Neufield M, McCarry B et al., Remediation of refractive amblyopia by optical correction alone. Ophthal Physiol Opt. 2002;22:296-299 (Pubitemid 41711138)
13. Newsham D. A randomised controlled trial of written information: The effect on parental non-compliance with occlusion therapy. Br J Ophthalmol. 1997;86:787-791. (Pubitemid 34713167)
14. Newsham D. The effect of recent amblyopia research on current practice in the UK. Br J Ophthalmol. 2010;94:1352-1357.
15. Pediatric Eye Disease Investigator Group. A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology. 2006a;113:904-912.
16. Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006b;113:895-903.
17. Pediatric Eye Disease Investigator Group. Treatment of strabismic with refractive correction. Ophthalmology. 2007;143:1060-1063.
18. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278.
19. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121(11): 1625-1632.
20. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004;111:2076-2085.
21. Pediatric Eye Disease Investigator Group. Pharmacologic plus optical penalization treatment for amblyopia: Results of a randomized trial. Arch Ophthalmol. 2009;127:22-30.
22. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003a;121:603-611.
23. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003b;110:2075-87.
24. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123(4):437-47.
25. Pradeep A, Proudlock FA, Awan M, Bush G, Gottlob I. Can Amblyopia Treatment Be Optimised? Invest Ophthalmol Vis Sci. 2010;51: E-Abstract 4756.
26. Repka MX, Kraker RT, Beck RW, et al. Treatment of severe amblyopia with atropine: Results from two randomized clinical trials. J AAPOS. 2009;13:258-263.
27. Scheiman MM, Hertle RW, Kraker RT, Beck RW, Birch EE, Felius J, Holmes JM, et al. Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: A randomized trial. Arch Ophthalmol. 2008;126:1634-1642.
28. Stewart CE, Moseley MJ, Fielder AR, Stephens DA, and the MOTAS cooperative. Refractive adaptation in ambyopia: Quantification of effect and implications for practice. Br J Ophthalmol. 2004a;88:1552-1556. (Pubitemid 39573596)
29. Stewart CE, Moseley MJ, Stephens DA, Fielder AR& the MOTAS cooperative. The Treatment Dose-Response in Amblyopia Therapy: Results from the Monitored Occlusion Treatment of Amblyopia Study (MOTAS) Invest Ophthalmol Vis Sci. 2004b;45:3048-3054. (Pubitemid 39121835)
30. Stewart CE, Stephens DA, Fielder AR, Moseley MJ, ROTAS Cooperative. objectively monitored patching regimens for treatment of amblyopia: Randomised trial. BMJ. 2007; 335:707-711. (Pubitemid 47582980)
31. Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Br J Ophthalmol. 2002;86:915-919. (Pubitemid 34827974)